Article

Five Best Practices To Ensure Quality Active Pharmaceutical Ingredients

Pharmaceutical-Drug-Manufacturing-GettyImages-1405788565

As the growing number of vaccines and novel formulations targeting niche therapeutic areas drives demand for active pharmaceutical ingredients (APIs), it is important to develop robust, reliable processes to safeguard these materials. Ensuring a robust API supply is critical for pharmaceutical companies, and manufacturers around the world shoulder a tremendous responsibility to assure the quantity, quality, and continuity of supply.

Employing processes such as routine comprehensive audits and assuring cGMP compliance to ensure APIs are robust, risk-based, and error-free is crucial for enabling you to deliver medicines that meet your patients’ complex needs. Explore the best practices for providing patients with the highest possible quality of treatment that meets their therapeutic requirements.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online